Refractive Disorders and Seric Vitamin D Level in Children With Disabilities
Launched by HOLHOS LARISA BIANCA · Mar 30, 2021
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
Refraction measurement will be done by the investigator in all 161 children. Visual acuity is checked, initial and after correction with proper correction. Vitamin D level is dosed from all the children in order to make correlations with the visual acuity, refractive status and risk for visual impairment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • children with disabilities and healthy children
- Exclusion Criteria:
- • children diagnosed with another chronic diseases
About Holhos Larisa Bianca
Holhos Larisa Bianca is a clinical trial sponsor dedicated to advancing medical research and innovation. Committed to improving patient outcomes, the organization focuses on the development of novel therapies and interventions across various therapeutic areas. With a team of experienced professionals, Holhos Larisa Bianca ensures rigorous adherence to regulatory standards and ethical practices throughout the clinical trial process. Their collaborative approach fosters partnerships with healthcare providers, researchers, and participants, aiming to facilitate groundbreaking discoveries that enhance the quality of care and address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Marghita, Bihor, Romania
Patients applied
Trial Officials
Holhoș L Bianca, Doctor
Principal Investigator
Faculty of Medicine and Pharmacy Oradea
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials